Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia.
Microglial activation has been implicated in various neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and HIV encephalopathy. Phytoestrogens have been shown to be neuroprotective in neurotoxicity models; however, their effect on microglia has not been well established. In the current study, we report that the soy phytoestrogens, genistein, daidzein, and coumestrol, decreased nitric oxide (NO) production induced by lipopolysaccharide (LPS) in the rat microglial cell line (HAPI). The levels of inducible NO synthase (iNOS) mRNA and protein expression were also reduced. Transcription factors known to govern iNOS expression including interferon regulatory factor-1 (IRF-1) and phosphorylated STAT1 were down regulated. These observations explain, at least in part, the inhibitory effect of phytoestrogens on NO production. The levels of monocyte chemoattractant protein-1 and interleukin-6 mRNA, proinflammatory chemokine and cytokine associated with various neurological disorders, were also reduced following LPS stimulation when HAPI cells were pretreated with phytoestrogens. Hence, genistein, daidzein, and coumestrol could serve as anti-inflammatory agents and may have beneficial effects in the treatment of neurodegenerative diseases.
Department of Pharmacology, Mahidol University, Phayathai, Bangkok, Thailand.
Nattinee
N
Jantaratnotai
Pongsak
P
Utaisincharoen
Pimtip
P
Sanvarinda
Anusorn
A
Thampithak
Yupin
Y
Sanvarinda
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002461:Cell Line, Transformed; D018932:Chemokine CCL2 / Q000378:metabolism; D004195:Disease Models, Animal; D005786:Gene Expression Regulation / Q000187:drug effects; D050856:Interferon Regulatory Factor-1 / Q000235:genetics / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D008070:Lipopolysaccharides / Q000276:immunology; D017628:Microglia / Q000187:drug effects* / Q000276:immunology*; D019636:Neurodegenerative Diseases / Q000188:drug therapy* / Q000276:immunology; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009569:Nitric Oxide / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism; D048789:Phytoestrogens / Q000494:pharmacology*; D051381:Rats; D050794:STAT1 Transcription Factor / Q000235:genetics / Q000378:metabolism; D013025:Glycine max / Q000276:immunology
D000893:Anti-Inflammatory Agents; C491766:Ccl2 protein, rat; D018932:Chemokine CCL2; D050856:Interferon Regulatory Factor-1; D015850:Interleukin-6; D008070:Lipopolysaccharides; D018696:Neuroprotective Agents; D048789:Phytoestrogens; D050794:STAT1 Transcription Factor; D009569:Nitric Oxide; D052247:Nitric Oxide Synthase Type II
Cytokines; Microglia; Neuroinflammation; Nitric oxide; Phytoestrogens